Synlait Milk (SML) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
18 May, 2026FY24 key achievements
Delivered a balance sheet reset through a shareholder loan, equity raise, and bank refinancing, significantly reducing debt.
Settled all disputes with The a2 Milk Company, including those related to exclusivity and pricing.
Completed a strategic review of North Island operations, now focusing solely on Advanced Nutrition products.
Expanded customer base in South East Asia across Advanced Nutrition, Foodservice, and Consumer units.
Retained milk supply by offering competitive advance rates and one-off milk price payments.
Financial restructuring and capital management
Raised $130 million via shareholder loan in July 2024, used to repay bank debt.
Raised approximately $217.8 million through an equity raise in September 2024, repaying further bank debt and retail bonds.
Secured a $450 million bank refinancing package, with $169 million of $180 million in bonds repaid by December 2024.
FY25 strategic priorities
Focus on growing secured milk supply and attracting key talent.
Target new customer growth to increase earnings and capacity utilization.
Emphasize new product development and market entry.
Prioritize CEO recruitment and operational performance to drive cash flow.
Latest events from Synlait Milk
- Net loss of $80.6 million, high debt, and asset sale drive a challenging but hopeful recovery.SML
H1 202616 Jun 2026 - North Island asset sale and record FY25 results drive strategic reset and debt reduction.SML
H2 202516 Jun 2026 - Profitability restored with strong EBITDA, reduced debt, and ongoing refinancing and supply risks.SML
H1 202516 Jun 2026 - Major FY24 loss, balance sheet reset, and recovery hinges on trading and milk supply retention.SML
H2 202416 Jun 2026 - North Island asset sale to Abbott and debt reduction strategy mark a pivotal reset.SML
Investor presentation18 May 2026 - Asset sale and board changes passed with over 99% approval, targeting debt reduction and growth.SML
AGM 20253 Feb 2026 - Major loss, balance sheet reset, and FY25 growth priorities with strong shareholder backing.SML
AGM 202412 Jan 2026